The MRL-lpr/Ipr mouse strain is a model of systemic autoimmune disease. In this model, intrinsic defects of intrathymic T cell development include defective deletion of self-reactive T cells and expression of endogenous retroviruses. Defective deletion of self-reactive T cells in the thymus has been proposed to be due to a germline mutation in the Fas apoptosis gene. Using different fragments of a Fas cDNA probe, we determined that the Ipr/lpr mutation is a 5.3-kb insertion of DNA within the second intron of the Fas gene. cDNA corresponding to this region was then derived from thymic RNA from MRL-Ipr/Ipr and MRL-+/+ mice using the polymerase chain reaction. All thymic KNA samples from MRL-Ipr/lpr mice yielded a unique product that was 168 bp larger than that of MRL-+/+ mice. Complete sequence analysis indicated that this inserted sequence had 98% homology with a sequence from the 3' long terminal repeat of the early transposon (Egh). RNA analysis indicated higher expression of E~ KNA in the thymus of MRL-Ipr/lpr than MRL-+/+ mice. The interdependence of ETn expression and abnormal Fas expression was then analyzed in a CD2-Fas transgenic mouse model in which a fuU-length murine Fas cDNA under the regulation of the CD2 promoter and enhancer was used to correct defective Fas expression in T cells of MtLL-IF/I F mice. In these mice, reduced thymic E~ expression was observed, confirming that high E~ expression is rdated to abnormal Fas expression. These results establish a link between endogenous retrovirus expression, abnormal Fas expression, and autoimmune disease.
T he homozygous expression of the Ipr/lpr gene leads to autoimmunity and lymphadenopathy in different strains of mice, including MKL, C57BL/6, C3H, AKR, and BALB/c (1). The Ipr gene has been identified as a point mutation in the intracellular region of the Fas gene in CBA/J-Iprr mice (2) . The functional significance of this point mutation has been demonstrated in transfection studies using a normal intracellular region of the Fas gene, or an intracellular domain containing this point mutation, ligated to the extracellular domain of the human Fas gene. After transfection into L929 cells and Fas crosslinking of the expressedJas molecules with anti-human Fas antibody, apoptosis occurred in cells transfected with the normal chimeric Fas gene, but not in cells expressing the chimeric Fas gene using the mutated intracellular domain (2) . The Fas gene also has been found to be abnormal in MKL-Ipr/Ipr mice in which Southern blot analysis indicated altered restriction enzyme digestion (2, 3) and Fas R.NA expression was not detectable in the thymus (2) . These results led to the conclusion that the Fas mutation in MRL-Ipr/lpr mice was different from the mutation in CBA/ J-lprcs mice, and that in MRL-Ipr/lpr mice the mutation leads to disruption of normal transcription of the Fas gene. Different strains of Ipr/Ipr mice develop different types of lymphoproliferative autoimmune disease (1). Genetic differences between the different strains of Ipr/Ipr mice play a role in determining the levels in autoantibody production, the type and severity of autoimmune disease, and extent of lymphoproliferation (1, 4, 5) . Genes determining the severity of renal disease in mice expressing the Ipr/Ipr gene have been mapped to chromosomes 7 and 12, whereas genes associated with arthritis, although known to exist, have not yet been mapped (3) (4) (5) . The heterozygous expression of the Ipr gene also leads to a less severe form of lymphoproliferative autoimmune disease (6) . It is not yet known if these disease differences are related to differences in expression of the Fas gene, or to the influence of other genes in the immune response.
We have previously reported that the Fas mutation was due to the insertion of a retrotransposon in the Fas gene (7) . This early transposon (ETn) 1 was found to be inserted within transcripts of the otherwise normal Fas gene. At least two abnormal sized transcripts of the Fas gene contained tran-scripts derived from the E~. One transcript was a short 168-bp sequence inserted between the second and third exon. In ad- 
Materials and Methods
Normal Mice. The original breeding pairs of MRblpr/lpr and MR.b+/+ mice were obtained from The Jackson Laboratory (Bar Harbor, ME).
Production of CD2-Fas Trunsgenic MRL.lpr/lpr Mice. The 1.1-kb full-length Fas cDNA was obtained by PCK amplification of cDNA made from thymus mRNA from MR.b+/+ mice as described brow. This was cloned into an EcoKI site in front of exon 1 of a human CD2 minigene consisting of 5.5 kb of 5' flanking sequence, emn 1, the first intron, fused e~ons 2-5, and 2.1 kb of the 3' flanking sequence. The Y sequence has been shown to be sufficient to allow T cell-spedfic, copy-dependent, integration-independent expression in transgenic mice (8, 9 Northern Blot Analysis. RNA was prepared as described previously (10). 5 #g of poly(A) + KNA was denatured at 65~ for 5 rain in dectrophoresis buffer (0.4 M 3-morpholinopropanesulfonic acid, 0.1 M sodium acetate, 2 mM EDTA pH = 7.0) containing 6% formaldehyde and 50% formamide, and size fractionated by electrophoresis through 1% agarose gels containing 0.6% formaldehyde. Gels were stained with ethidium bromide to assure integrity of the loaded KNA. RNA was transferred to nylon membranes (Nitroplus 2000; Micron Separations Inc., Eastboro, MA) and baked for 2 h at 80oC in a vacuum oven. Membranes were prehybridized and then hybridized with 1-3 x 106 cpm/ml of different DNA probes that had been hbeled with 3zp by random priming to a specific activity of 109 cpm/#g. Filters were then washed with 2x SSC + 0.1% SDS at 42~ for 30 min and then with 0.1x SSC + 0.1% SDS at 60~ for 30 min; they were then exposed to XAK-2 film (Eastman Kodak, Rochester, NY) at -70~ with intensifying screens.
PCR Analysis. Thymuses of mice were homogenized and total RNA was extracted from the homogenates by the guanidiniumCsCI method. Total RNA (2-4/~g) from each tissue was used for cDNA synthesis followed by PCR amplification using an KNA-PCR kit (Perkin-Elmer Corp., Norwalk, CT). Reaction conditions were as specified by the manufacturer. An oligo(dT) primer was used to initiate cDNA synthesis. 30 PCR cycles (1 min at 95~ 1.5 min at 55~ 2.5 min at 72~ were run followed by extension for 10 min, and the amplification products were visualized after electrophoresis on agarose gels (1.0%) under ultraviolet illumination in the presence of ethidium bromide. Gels were blotted and hybridized to a labeled internal Fas probe to verify that the bands were Fas specific. The fuU-length Genomic Cloning. High molecular weight DNA from the thymus of MtLblpr/lpr and MKI_,+/+ mice was digested with PstI and HincII. The digested sample was divided into several wells and subjected to electrophoresis through 0.8% agarose. After electrophoresis, a portion of the gel was blotted and probed with the 345-bp HincII fragment of Fas and the 168-bp ETn fragment, and another portion of the gel was sliced into thin sections representing different molecular weights. The gel slices corresponding in size to bands hybridizing with the Fas or ETn probes were extracted from the gel using Geneclean II (Bio 101, La Jolla, CA). DNA fragments ranging from 3.8 to 5.6 kb were amplified using the appropriate Y or 5' Fas cDNA primers in combination with ETn primers from the 168-bp sequence (see Fig. 2 ) and published ETn sequences (12) . PCK products were doned into the PCK 2000 vector (Invitrogen, San Diego, CA) for sequence analysis.
Sequence Analysis. Sequence analysis was carried out on doublestranded DNA derived from PCK amplification and cloning into the PCK 2000 (Invitrogen). Sequence analysis was carried out in both directions using 5' and 3' universal primers and Fas-specific primers. For genomic sequencing, universal primers were used to determine the sequence of both the 3' end of the second exon and the 5' end of the third exon and flanking intronic sequences.
DNA Probes. The full-length murine Fas cDNA probe (49-1033 bp) was derived by PCK amplification of cDNA prepared from MKb+/+ thymus mRNA as described above and using previously described Fas primers (11) . A probe corresponding to the first and second exons of Fas, which are 5' of the normal ETn insertion, was the 170-bp PstI-HinclI fragment (49-219 bp) derived from the full-length Fas cDNA clone (Fig. 2 a) . A probe corresponding to the remainder of the extracellular domain was the 345-bp HinclI fragment (219-569 bp) derived from the fuU-length Fas cDNA clone.
The ETh probe was the 168-bp ETn sequence that was isolated by PCR amplification of cDNA prepared from MRL.Ipr/Ipr thymus mRNA and reamplified using primers specific for the 5' and 3' sequences of ETn. The/3-actin probe was a gift from Dr. K. Gordon (GenZyme Corp., Framingham, MA) (13) .
Results

The Ipr Mutation Results from a 5.3-kb Insertion of DNA.
High molecular weight DNA from the kidney and thymus of MRL-Ipr/Ipr and MILL-+ / + mice was digested with various restriction enzymes and probed with a 345-bp sequence corresponding to the extracdlular domain of the Fas cDNA (Fig. 1 a) . There was no difference in restriction fragment lengths between high molecular weight DNA from the kidney and the thymus (data not shown). There was an additional 5.3 kb of DNA within the extracellular domain of the genomic Fas gene from MRL-Ipr/lpr mice as determined by restriction fragment length analysis of Southern blots prepared using multiple single and double enzyme digestions and hybridization with a 170-bp cDNA probe corresponding to the first and second exons ofFas cDNA (49-219 bp), an extracellular domain probe (219-569 bp), and a full-length Fas cDNA probe (49-1033 bp). The inserted DNA contained additional digestion sites for EcoRI, HindIII, and PvuII but not for BamHI (Fig. 1 b) . Using probes corresponding to exons 1 and 2, or a HincII cDNA fragment corresponding to the extracellular domain, the insert was localized to the region of the Fas gene corresponding to the second intron (Fig. 1 b) . Fas RNA, cDNA corresponding to the extracdlular domain was derived from thymus RNA from several MRL-Ipr/Ipr and MRL-+ / + mice using the PCK and primers P2 and P3 (Fig. 2 a) . All RNA samples from the thymus of different MRL-lpr/lpr mice yielded a unique PCK product that was 168 bp larger than that of wild-type M R L -+ / + mice (Fig. 2 b) . The mutation of the Fas gene in MRL-Ipr/lpr mice was confirmed to be in the extraceilular domain by sequencing, using full-length primers P1 and P4 (Fig. 2 a) (Fig. 2 c) MRL-Ipr/+, BXSB male, and NZB mice and from the BW5147 cell line. In M R L -+ / + mice there was a 2.2-kb normal-sized Fas cDNA (Fig. 3 a, lane 1-3) . In contrast, in 1-mo-old MRL-Ipr/Ipr mice there were multiple bands ranging from 2 to 10.5 kb (Fig. 3 a, lanes 4 and 6) . Fas expression was highest in the thymus of 1-mo-old MKL-lpr/Ipr mice, and decreased in 3-mo-old mice (Fig. 3 a, lane 5) . When identical blots were hybridized with a 170-bp PstI/HinclI Fas cDNA fragment corresponding to the first and second exons, Fas expression in MRL-lpr/Ipr mice was very low compared with Fas expression in MRL-+ / + mice (Fig. 3 b, lanes 4-6) .
Insertion of ETn in the Extracelhlar
A faint abnormal high molecular weight species of 10.5 kb was present using this 5' probe ( Fig. 3 b, lane 4, arrow) . When blots were probed with a 345-bp HincII Fas cDNA fragment corresponding to the extraceUular domain of Fas, the primary species of RNA expressed in the thymus of young MRLIpr/Ipr mice was a high molecular weight 10.5-and 9.5-kb transcript (Fig. 3 c) . These results indicate that the Fas mutation leads to production of abnormal high molecular weight Fas transcripts in the thymus. There was high expression of the 2.2-kb Fas transcript in (MRL-Ipr/Ipr x MILL-+ / + )Ft mice, and also in BXSB male and NZB autoimmune mice (Fig. 3, a-c; lanes 7-9) . Expression of normal levels of/=as RNA in BXSB and NZB mice indicates that autoimmune disease in these mice is not related to defective expression of Fas KNA.
The 168-bp ETn probe, derived from within the Fas cDNA prepared from thymus KNA of MRL-lpr/Ipr mice, strongly hybridized to a 5.7-kb full-length E~ transcript that was expressed in the thymus of younger MRL-Ipr/lpr mice (Fig.   3 d, lanes 4 and 6) , but not strongly expressed in the thymus of older MRL-Ipr/Ipr mice (Fig. 3 d, lane 5) or in the thymus ofMRL-+ / + mice (Fig. 3 d, lanes 1-3) . RNA corresponding to the fuU-length 5.7-kb E~ transcripts was also abundant in the thymus of MRL-Ipr/+ and BXSB mice, and also in (Fig. 3 a, lanes 7-10) .
Germline Organization of the Mutated Fas Gene in lpr Mice.
Using PCR primer pairs to the 3' end of Fas exon 2 and the 5' end of the 168-bp ETn found in the Fas transcript or the 5' end ofFas exon 3 and the 3' end of ETn, the sequences of cloned genomic fragments isolated using the 345-bp HinclI fragment of Fas and the 168-bp ETn fragment were determined (Fig. 4) . In MRL-Ipr/Ipr mice the ET~ sequence began at the 5' terminal of exon 2 and continued for an additional 5.3 kb. There was a conserved splice consensus nucleotide sequence on the 3' end of exon 2-intron 2 (G/A) and on the 5' end of the 168-bp ET~ (A/G), which was found to be spliced into the Fas transcript. Also, there was a conserved splice consensus at the 3' end of the 168-bp ETn (A/G) and on the 5' end of the Fas exon 3 (A/G). These splice consensus sequences allow for splicing of the 168-bp ETn into the Fas cDNA. Additional ETn sequence was present in the MRLIpr/Ipr mice directly adjacent to the 3' terminus of the second exon (Fig. 4) . In MKL-+/+ and MRL-lpr/Ipr mice there was an additional 3.5 kb of intron sequence consistent with the restriction map shown in Fig. 1 .
Downregulation of ETn in a CD2-Fas Transgenic MRL-lpr/Ipr
Mice. To determine if high ET~ expression was dependent on abnormal Fas expression, CD2-Fas transgenic mice were produced that used a full-length murine Fas cDNA under the regulation of the CD2 promoter and enhancer (8, 9) to correct defective Fas expression in T cells of MRL-Ipr/Ipr mice. The presence of the Fas transgene resulted in reduction of expression of ETn in the thymus, suggesting that high ETn expression is related to abnormal Fas expression (Fig. 5 A) . Northern blot analysis indicated that there was high expression of the Fas transgene in the thymus and lymph node, but not in the brain of 4-wk-old CD2-Fas transgenic MRLIpr/Ipr mice (Fig. 5 B) . 465 Wu et al.
Discussion
Watson et al. ( of restriction enzymes, including HindlII and BanlI, which has a restriction site in ETn (Fig. 1) , and HinclI and PstI (data not shown). It is unlikely that there is a difference in the mice, since both analyses were carried out on MRL-Ipr/Ipr mice obtained from The Jackson Laboratory. ETn retrotransposon transcription occurs during early embryonic development in mice (16, 17) . Increased expression of endogenous retroviruses in the thymus of autoimmune strains has been proposed to be related to development of autoimmune disease (18) (19) (20) . In this paper, we report that there is also increased expression of full-length E~ endogenous retrovirus in the thymus of MRL-Ipr/lpr mice and BXSB mice (Fig. 3) . Inhibition of translation of retroviral transcripts by antisense KNA has been reported to result in increased proliferation of lymphocytes leading to the speculation that full-length retroviral transcripts and protein products are a compensatory mechanism for increased lymphocyte proliferation in autoimmune mice (18) . A second mechanism of association of retroviruses with autoimmunity is suggested by the present data, which suggest that increased retroviral expression may be related to defective Fas expression in MRLlpr/lpr mice.
The ETn retrotransposon in the second intron of the Fas gene might interfere with Fas expression by promoting abnormal transcription initiation and interfering with abnormal splicing. High expression of ETn correlates with high expression of an abnormal large-sized Fas transcript with a molecular weight of "~10.5 kb (Fig. 3, lanes 4 and 6) . The largest Fas transcript corresponds in size with an abnormal ETn transcript of the same size. This transcript contains both 5' and 3' Fas cDNA sequences because it is detected by both the 5' 170-bp Pst-1/HincII Fas probe and the 3' 345-bp HincII Fas probe. A lower unusual Fas transcript with an approximate molecular weight of 7.5 kb, which retains 5' and 3' Fas sequences (Fig. 3, lane 4) , does not hybridize with the 168-bp ETn probe, indicating that the 168-bp portion of ETn is spliced out of this transcript. Other aberrant splicing events can lead to Fas transcripts that contain only 168 bp of ETn sequences (Fig. 2) . These results suggest that thymic developmental factors that lead to high E~ expression also promote production of an abnormally large Fas transcript in MKLIpr/lpr mice due to the integration of E~ within the second intron of the Fas gene.
In MRL-Ipr/+ heterozygous mice, there was increased expression of ETn and abnormal Fas, despite the presence of apparently normal levels of Fas transcription from the unmutated allele. It is possible that abnormal Fas and high ETn are expressed in a subpopulation of thymocytes that express low levels of normal Fas and exhibit abnormal thymic development. This was investigated in CD2-Fas transgenic MRLIpr/Ipr mice. In these mice, Fas expression is regulated by the CD2 promoter/enhancer, which results in high expression of/:as in all thymocytes, and elimination of ETn expression (Fig. 5) . These results suggest that Fas expression and ETn expression are functionally related.
We have also observed that ETn expression is decreased and Fas expression is partially normalized in TCK-B transgenic mice (Wu, J., andJ. D. Mountz, manuscript in preparation). We have previously demonstrated that in TCK-B transgenic mice, there is nearly total elimination of the CD4-CD8-B220 + subpopulation of T cells and lymphoproliferation, but not elimination of autoimmunity (21, 22) . We have recently demonstrated that there is decreased apopotosis of thymocytes of MRL-Ipr/lpr mice and an increase of a large, proliferating CD4 + CD8 + subpopulation of thymocytes (22) . The TCK-B transgene was found to reduce these large, proliferating CD4 + CD8 + thymocytes, and there was no difference between this population in TCK-/~ transgenic MKL-lpr/Ipr mice and the same population in MRL-+/+ mice. These results suggested that the presence of the TCK-B transgene corrected the defect in early T cell development related to lymphoproliferation despite the presence of a germline mutation of the Fas apoptosis gene. Rearrangement of the TCK-B chain gene has been proposed to play a critical role in early T cell development in the thymus (23, 24) . The TCR-B transgene suppresses rearrangement of the endogenous TCK-~ gene (25) . suggest that retrovirus expression is intimately related to abnormal Fas gene transcription and abnormal lymphocyte development. For other autoimmune strains of mice, there is no evidence for such a direct association of retrovirus expression and altered expression of genes related to autoimmunity. For the CBA/J-lpr r mice, the genetic defect of the Fas gene is a single point mutation in the cytoplasmic signaling region of the gene, and currently there is no evidence to suggest that this is related to the presence of the ETn retrotransposon within this gene. It will be necessary to characterize the genomic organization of the Fas gene in CBA/J-lpr~g mice to determine if a retrovirus might result in abnormal splicing and this point mutation. Likewise, cloning and characterization of defective autoimmune genes in other strains of mice, including gld/gld, NZB, and BXSB, will be necessary to determine if retroviruses play a critical role in abnormal expression of autoimmune genes other than the Fas gene.
